Literature DB >> 25343241

Clinical Neuropathology image 6-2014: Corpora amylacea replacing cornu ammonis (CACA).

Gabor G Kovacs1, Daniele Risser.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25343241      PMCID: PMC4251082          DOI: 10.5414/np300831

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


× No keyword cloud information.
Corpora amylacea (CA) are globular bodies usually 10 – 50 µm in diameter mainly made up of glucose polymers (polyglucosans), which stain strongly with periodic acid-Schiff (PAS) staining. They are commonly seen in different subependymal and subpial regions, fornix, olfactory tract, posterior column of the spinal cord, and velum medullare anterius [1]. Large amounts of CA have been reported in a subset of patients with temporal epilepsy specimens, even where unusual and extensive amounts of CA replaced the pyramidal layers of the cornu ammonis [2]. However, others concluded this to be a pathological response to neuronal cell loss with no clear clinical and quantitative hippocampal MRI correlates [3]. We present here a case where extensive amounts of CA were detected. A 73-year-old man living in a nursery home fell and suffered head trauma. We do not have any documentation of follow-up neurological examinations of the patient. Following neurosurgical intervention, repeated cranial CT revealed progressively increasing subdural and subarachnoidal bleedings with severe brain edema and the patient died. Forensic pathological examination was performed and blocks of the cerebellum and hippocampus formation were sampled to evaluate the degree of hypoxic/ischemic damage. There was severe neuronal loss in the cornu ammonis associated with abundant PAS-positive CA replacing the pyramidal layers (Figure 1A, B). Mostly the smaller CA showed GFAP immunoreactivity hugging the globular bodies (Figure 1C). Axons seemed to be distorted in SMI-31 and -32 neurofilament stainings (Figure 1D). Interestingly, immunostaining for phosphorylated TDP-43 showed prominent immunoreactivity in the CA1 (Figure 1E) representing a neurodegenerative process. Furthermore, immunostaining for phospho-τ (AT8) showed prominent τ-astrogliopathy affecting the cornu ammonis subregions and the dentate gyrus (Figure 1F, G); in sum reminiscent of that described in a subset of elderly individuals [4, 5]. CA was present also related to τ-positive astrocytic processes (Figure 1G, right upper inset). CA was prominent in the cerebellum also where it associated with τ-pathology (Figure 1H).
Figure 1

Clinical Neuropathology image 6-2014: Corpora amylacea replacing cornu ammonis (CACA).

The conditions that favor the development of CA, include aging, neurodegeneration, chronic hypoxia, and diabetes mellitus [6]. CA is thought to be mostly of astrocytic origin and their development is considered to be triggered by cellular injury [1, 7]. Although in our case we cannot trace the etiology of the abundant CA or their relation to clinical symptoms, it is of note that the CA associated with intensive τ-astrogliopathy and with TDP-43 proteinopathy. Our observation further emphasizes the need of ongoing neuropathological studies to understand the spectrum of pathologies in the human brain.

Conflict of interest

The authors report no conflict of interest.
  7 in total

1.  Corpora amylacea in hippocampal sclerosis.

Authors:  W Van Paesschen; T Revesz; J S Duncan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-10       Impact factor: 10.154

2.  Corpora amylacea in hippocampal sclerosis.

Authors:  L Leel-Ossy
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-10       Impact factor: 10.154

3.  Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series.

Authors:  Gabor G Kovacs; Ivan Milenkovic; Adelheid Wöhrer; Romana Höftberger; Ellen Gelpi; Christine Haberler; Selma Hönigschnabl; Angelika Reiner-Concin; Harald Heinzl; Susanne Jungwirth; Wolfgang Krampla; Peter Fischer; Herbert Budka
Journal:  Acta Neuropathol       Date:  2013-07-31       Impact factor: 17.088

4.  New data on the ultrastructure of the corpus amylaceum (polyglucosan body).

Authors:  L Leel-Ossy
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

5.  Corpora amylacea replace the hippocampal pyramidal cell layer in a patient with temporal lobe epilepsy.

Authors:  S Nishio; T Morioka; T Kawamura; K Fukui; H Nonaka; M Matsushima
Journal:  Epilepsia       Date:  2001-07       Impact factor: 5.864

6.  Corpora amylacea could be an indicator of neurodegeneration.

Authors:  S K Singhrao; J W Neal; G R Newman
Journal:  Neuropathol Appl Neurobiol       Date:  1993-06       Impact factor: 8.090

7.  Patterns of hippocampal tau pathology differentiate neurodegenerative dementias.

Authors:  Ivan Milenkovic; Tatjana Petrov; Gabor G Kovacs
Journal:  Dement Geriatr Cogn Disord       Date:  2014-09-05       Impact factor: 2.959

  7 in total
  2 in total

1.  Corpora Amylacea of Brain Tissue from Neurodegenerative Diseases Are Stained with Specific Antifungal Antibodies.

Authors:  Diana Pisa; Ruth Alonso; Alberto Rábano; Luis Carrasco
Journal:  Front Neurosci       Date:  2016-03-08       Impact factor: 4.677

2.  Human and Microbial Proteins From Corpora Amylacea of Alzheimer's Disease.

Authors:  Diana Pisa; Ruth Alonso; Ana Isabel Marina; Alberto Rábano; Luis Carrasco
Journal:  Sci Rep       Date:  2018-06-29       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.